Sleep medicine

Sleep disturbance and decrements in morning energy contribute to a higher symptom burden in oncology patients.

Sleep disturbance is associated with perturbations in immune-inflammatory pathways in oncology outpatients undergoing chemotherapy.

Oncology outpatients with worse depression and sleep disturbance profiles are at increased risk for a higher symptom burden and poorer quality of life outcomes.